Trial Profile
The Effects of Ethanol on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Retigabine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Retigabine (Primary)
- Indications Amyotrophic lateral sclerosis; Lennox-Gastaut syndrome; Partial epilepsies
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Bausch Health Companies; Valeant Pharmaceuticals International
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 14 Apr 2011 New trial record